Solvency II - QIS5 Workshop

Size: px
Start display at page:

Download "Solvency II - QIS5 Workshop"

Transcription

1 Solvency II - QIS5 Workshop 15/9/2010 Presentation: QIS5 timelines and procedures & general overview of the QIS5 Files and Spreadsheets Speaker: Nicos Koullapis Senior Officer Insurance Companies Control Service

2 2 1. QIS5 timelines July EC/EIOPC provide the final technical specifications to CEIOPS August Nov - Perform QIS5 exercise End of October for solo entities Mid November for Groups Dec 2010 Jan Preparation of National QIS5 Reports Febr - April Preparation of CEIOPS QIS5 Report 2. QIS5 process Technical Specifications document: On 5/7/2010, the final version of the Technical Specifications document has been released from CEIOPS and made available to companies for study. Q & A process: The QIS5 process started on 2/8/2010 with the Q & A process. Questions, based on the July 2010 QIS5 technical specifications document, are sent to the national supervisor, and when the national supervisor can not answer a question the question is redirected to the QIS5 task-force in CEIOPS, which is bound to provide an answer within a period of 5 working days. Every 10 days, the Q & As document is updated and posted in CEIOPS website (in the QIS5 area). During the first week of August the Insurance Companies Control Service (ICCS) has collected the first set of questions, from companies operating and supervised in Cyprus, and delivered it to the

3 3 CEIOPS QIS5 task-force on 10/8/2010. As at 10/9/2010, 4 sets of questions, with a total of 29 questions, have been delivered from ICCS. Relevant answers have already been received for the first 3 sets. QIS5 spreadsheets and documents: During the last week of August CEIOPS published in its website (Solvency II QIS5 section) the set of spreadsheets and documents, with which the companies could start the study. The whole set of files has been circulated by the Insurance Companies Control Service to all the insurance companies in Cyprus on 30/8/2010. Updates of files: When updates of any of the files are available, CEIOPS informs accordingly the QIS5 participants (directly through its website and through the contact points of each national supervisory authority). Updates should be downloaded and should replace existing files each time such updates are published. In case a company has already inserted a number of values in an older version of a spreadsheet, it should use the respective transfer of data files, which are also published in CEIOPS QIS5 website, in order to transfer those values into the new updated spreadsheet. Submission of spreadsheets and questionnaires: By the end of October for Solo companies and middle of November for Group Companies, the companies will have to submit to the Supervisor their work and results. Insurers are encouraged to submit not only the completed QIS5 spreadsheet, but also any Helper tabs and similar programmes used to complete the main spreadsheet. These data greatly assist an assessment of the submission by the supervisor, and also, importantly, a productive feedback of the findings to the individual insurers. Companies are also reminded to submit the qualitative questionnaires.

4 4 Remember: For the European Commission, the main target of this exercise is to see the effects on SCR and own funds from a newrevised set of parameters and assumptions, which are applied on the exposures relating to the risks included in the SCR tree and on the 3 tiers relating to own funds. Therefore: These parameters and assumptions are not final, and the results should be used by the companies as a good, but not final, indication on which of their risks have the most significant SCR needs and for which risks there is a need for more attention and for possible reduction or mitigation. Feedback: The feedback we will get from the companies through the relevant questionnaires, is also important in the effort to finalize the standard approach parameters. Thus, any important issues and or difficulties and also any suggestions that you may have should be incorporated therein.

5 5 3. The Technical Specifications file - QIS5TS --date--. Doc This is a very important 300 pages document, which explains the methods and formulas and the rules and assumptions used for the calculation of the technical provisions (best estimate of future cash-flows plus risk margin), the valuation of assets and other liabilities, the classification of own funds and the calculation of the SCRs and the MCRs. Important Note: This file must be stored in the same directory with the QIS5 Solo --date--.xls file with which it is linked, and you must not change its name when you download it from the website.

6 6 4. The QIS5 Main Spreadsheet - QIS5 v--date--.xls This is the most important file. It is used for the input of information from the company and of values derived from all other ancillary programs, and for the presentation of the balance sheet and the solvency position of the company under QIS5. A comparison with the respective Solvency I figures is also provided therein. a. Important facilities of the QIS5 Main Spreadsheet It is accompanied by a comprehensive user manual. It contains hyperlinks with the Technical Specifications file, so that the user can easily find the paragraphs relating to the subject cell he/she is working on. It allows the user to choose the language with which he wishes to work with, in the Sheets «O. Language (cell H3)» and «Qis5.Lang.En (cella3)». It provides control cells, with which the user is notified whether an input or a result has an error. Through the Index sheet, which shows the structure of the spreadsheet, i.e. which sheets are included in it, and the color codes relating to the types of these sheets, the user is able to move faster and easier between the sheets by use of relevant buttons. Several colors are used for the various cells, in order for the user to know which cells are: Input cells (color: light blue), Intermediate calculations cells (color: terracotta light brown), Final result of a series of calculations cells (color: purple), and Final outcome of simple formulas calculations cells (color: yellow). It allows the user to delete any sheets he is not going to use, e.g. the Internal Models (IM..) sheets and/or the Groups (G..) sheets. It is accompanied by a word file with the name MAPS, in which the user can find all the abbreviations for the input and output items used in the

7 7 study and the full description/name of these items. This file is also connected with the Technical Specs file for the same reason. It is accompanied by a number of ancillary programs/spreadsheets, which allow the user to perform several calculations and approximations for a number of values he will need to input in the main spreadsheet. b. General Overview of the sheets included in the QIS5 Main Spreadsheet The purpose of this overview is to give the user a short tour amongst the sheets included in the QIS5 main spreadsheet. In the absence of lead insurance group undertakings, and due to time constraints, the overview focuses to solo companies, which are going to use the standard approach, and is in line with the manual for completion for solo companies. The user is allowed to delete any sheets which are not going to be used, e.g. sheets for insurance group undertakings and sheets for internal models. The Index sheet-tab This sheet shows the structure of the spreadsheet, i.e. which sheets are included in it, and also the color codes relating to the types of these sheets, and allows the user to move faster and easier between the sheets. The input sheets-tabs (Color: Light Blue) I. Participant In this tab general information is requested about the insurer. Note: The reporting year has already been set therein at 2009.

8 8 I. Valuation (5 sections) Section 1: Balance sheet - Assets In this section information is required on the value of the assets, on three bases: Current accounting bases (these should correspond to the information in the company s financial statements) Solvency I valuation principles (these should correspond to the information in the company s annual statutory accounts) QIS5 valuation principles (market consistent valuations) Section 2: Balance sheet Liabilities The liabilities are to be reported under the same three valuation bases indicated above for the assets. Section 3: Information on own funds Insurance companies are strongly advised to study for themselves the section in the Technical Specifications on Own funds, including transitional provisions to be used in QIS5, before inserting relevant information here. Section 4: Information on valuation methods applied to determine the Solvency II balance sheet This section requests information on the valuation methods used. Please note that all values are to be reported as a percentage of the total QIS5/Solvency II balance sheet. Section 5: Intragroup asset and liabilities, for undertakings belonging to a group Solo companies (not part of a group) may ignore this section. I. Assets (5 sections) Section 1: Information on bonds This section asks for a detailed breakdown of investments in borrowings by or demonstrably guaranteed by a national government, exposures to multilateral organisations and to the European Central Bank. Section 2: Information on currency risk exposures (in the currency used to fill the QIS5 spreadsheet)

9 9 This section asks for more detailed information on currency risk exposures. Section 3: Information on spreads - aggregates This section asks for more detailed information on spread products, broken down into various types and rating classes. (Helper tab is available). Section 4: Information on the concentration of assets used for market risk concentration calculation (Helper tab is available) Section 5: Information on the counterparty default risk (Helper tab is available) I. Participations This section asks for a detailed breakdown of the nature and value of any participations held by the insurer. I. Own funds items details (3 sections) Section 1: Info given on the Valuation tab on other capital elements No input cells. The information in this tab has already been supplied in the Valuation tab. Section 2: Calculation based on the detailed list of capital elements No input cells. This section provides a summary overview, based on the information to be provided in section 3 of this tab. Section 3: Detailed list of other capital elements. Some input is required. This section asks for detailed information on any other capital elements, which could be used under certain conditions and for a transitional period as Tier 1 elements. Please refer to the Technical Specifications when completing this section. I. Current situation (3 sections) Section 1: Current Solvency I position Here the user inserts the current solvency I amounts.

10 10 Note: The value for the minimum guarantee fund should be the one third of the required solvency margin, and not the absolute minimum amount. Section 2: Provisions calculated according to the current accounting bases (Solvency I valuation basis) - totals No input here. The totals in this section are calculated by the spreadsheet, based on the more detailed information to be provided in section 3. Section 3: Detailed information on the technical provisions valuated according to current bases (Solvency I valuation basis) This section asks for the amount of technical provisions, per line of business and per products category. The upper half of this section concern the gross technical provisions and the lower half the net technical provisions. For non-life obligations a distinction is also made between proportional and non-proportional reinsurance. Note: Insurers are requested to ensure consistency between the numbers provided here (and summarised in section 2) and the amounts reported in the balance sheet in the tab Valuation. I. Premiums (2 sections) Section 1: Premiums by lines of business and volume measures for underwriting risk This tab requests information about written and earned premiums, per line of business, for the year under consideration and for the year that follows, and the information are used later on in the calculation of the capital requirements. Note: The term P pp in column M is defined as the present value of net premiums of existing contracts which are expected to be earned after the year following the study year (i.e. for QIS5 this means from 2011 onwards) for each LoB. This term is only relevant for contracts with a coverage period that exceeds the year that follows the study year, thus for contacts with more than one year duration. For annual contracts without renewal options this value should be set to zero. Section 2: Premiums and expenses information needed for SCR and MCR calculations

11 11 Here the user should only input the annual expenses in respect of unitlinked business, and the premiums amounts for the year before the study year, i.e. the year Note: The expenses amount concerns the actual expenses incurred by the insurer, and not the expense loadings charged to the policyholders. I. QIS5 Insurance Obligations (5 sections) Section 1: Allocation of Health to the QIS5 segmentation This section asks for information on how the business currently regarded as Health insurance will be allocated to the QIS5 segmentation. The amounts requested are the technical provisions on a Solvency I basis, both gross and net. Note: In separate rows insurers must report the business amounts that in QIS5 will be allocated to Health SLT (similar to life type) and the amounts which relate to business with a non-slt character, and which will be allocated to non-life business. Section 2: Segmented calculations of the best estimate and recoverables (before risk margin) This section asks for detailed information on the gross best estimate, and on the reinsurance recoverables. Note: Any different from QIS4 technical provisions established for annuities stemming from non-life contracts, which are estimated using actuarial life techniques, should be reported under life insurance obligations and for non-life business, separate best estimates are required for the premium and the claims provisions. Section 3: (a) Risk margin, (b) technical provisions, (c) underwriting risks volume measures, (d) expected profits in future premiums (EPIFP) In this section the user should input the calculated risk margin (Helper tab is available), the gross and the net technical provisions, the underwriting risks volume measures and the expected profits in future premiums, for each of the identified in the sheet segments. Note: The Technical Specifications allow for a number of approaches to the calculation of the risk margin. Insurers who meet the conditions to use the simplifications, are nevertheless encouraged to try, if possible, to

12 12 carry out the standard calculations, so that the practicality of these is sufficiently tested. Section 4: (a) expected profits in future premiums (EPIFP) and (b) illiquidity premium information Here the user should report the allocation of the insurance obligations to the different illiquidity buckets, in terms of the amount of (best estimate) technical provisions in each bucket, for each line of business. Section 5: Other information needed for the SCR and MCR In this section the user should report some additional information on the best estimate amounts of certain categories of technical provisions. I. Geographical Diversification (2 sections) Section 1: Total and calculation of diversified volume measures for the non-life and Health non-slt underwriting risks modeling The information reported in this tab is used to calculate a possible diversification benefit reduction in the capital requirement due to geographical diversification, for the premium and reserve risk. Section 2: Net written premium and forthcoming premiums, net claims outstanding by geographical areas This section requests information on the amounts of premiums and claims provisions per line of business and per geographical area. Note: The net premiums and the net best estimate provisions for claims outstanding (net PCO) should be reported here. The results sheets-tabs (Color: Dark Blue) SF.SCR (9 sections) This sheet is a very important sheet (tab), as this is where the Solvency capital Requirements are calculated. The structure of this tab follows the structure of risks shown in the, well known by now, SCR risks tree (see Appendix). Sections 1-3 contain the amounts relating to the top end of

13 13 the SCR tree risks, while Sections 4-9 contain the amounts relating to the lower end of the SCR tree, with each section containing a further subdivision. Section 1: SCR and BSCR values, with the inclusion of the operational risk value and the possible adjustments due to profit sharing and deferred taxes. No input here. Section 2: Adjustment to SCR amounts for the risk absorbing effect of technical provisions and deferred taxes. Some input is required here in order to derive the adjustment amounts. Section 3: Operational risk amount. Some very little input here. Section 4: Intangible asset risk. No input here. Section 5: Market risk. Some input here. Sub-risks: Interest rate risk, Equity risk, Property risk, Spread risk, Currency risk, Concentration risk and Illiquidity premium risk. Section 6: Counterparty default risk. No input here. Section 7: Life underwriting risk. Some input here. Sub-risks: Mortality risk, Longevity risk, Life disability-morbidity risk, Life lapse risk, Expense risk and Revision risk. Life CAT risk. Section 8: Health underwriting risk. Some input here. SLT Health underwriting risk (similar to life sub-risks and techniques) Sub-risks: Mortality risk, Longevity risk, Disability-morbidity risk, Disability-morbidity risk for medical expense, Disability-morbidity risk for income protection,

14 14 Life lapse risk, Expense risk and Revision risk. Non-SLT Health underwriting risk (similar to non-life techniques) Sub-risks: Premium and reserve risk and Health non- SLT lapse risk. Note: Reserve risk relates to the risk that the BE for claims provisions may turn out to be insufficient, and it relates to a past risks period. Health CAT risk (for both SLT and Non-SLT Health) Section 9: Non-life underwriting risk. Some input here. Sub-risks: Non-life premium and reserve risk and Nonlife lapse risk Non-life CAT risk. SF.RFF (new) This tab is used to calculate own funds when ring-fenced funds exist and an adjustment to own funds is relevant. Note: Companies which are not using this sheet can delete it. SF.MCR (2 sections) Section 1: MCR Top level calculation Section 2: MCR Detailed calculation O. Overview sheet In this tab, the user can see a very good summary of the QIS5 results. No input required. Datasets sheets (Color: Grey) D. Datasets sheet This sheet stores all the input values and results in one long data column, and is very useful for checking purposes.

15 15 5. QIS5 Ancillary programs/spreadsheet tools The Non-life Simplifications tool The user can use this tool for the calculation, based on simplified approaches, of the technical provisions of non-life business (TP to TP.2.163, TP.7.59 to TP.7.63, TP.7.70 to TP.7.73, TP.7.83 to TP.7.88), i.e. the best estimate of the premiums provision, the best estimate for the outstanding claims and IBNR, and the best estimate for recoverables, which are required as input in the QIS5 Insurance Obligations sheet in the main spreadsheet. The Non-life best estimate (section V.2.2) tool along with a user guide With this tool, the user can calculate the best estimate for the outstanding claims provision (using the chain ladder method), for non-life business, which are required as input in the QIS5 Insurance Obligations sheet in the main spreadsheet. Discounting tool (TP.3.1 to TP.3.11) This tool could be useful for the discounting of cash-flows, when these are derived by use of a cash-flows model, to get the present values of these cash-flows under the risk free rate conditions (for best estimate purposes) and under the stress conditions (for interest rate risk and liquidity premium risk purposes). Risk margin tool (TP.5.1 to TP.5.74) This tool allows the user to calculate the risk margin values, and then insert them in the SF.SCR sheet of the main spreadsheet. The Non-life Undertaking specific parameters tool (SCR.10.1 to SCR.10.61) This tool allows the user to calculate its own (specific) standard deviation parameters, which are required as input in the non-life premium and reserve risk section in the SF.SCR sheet of the main spreadsheet.

16 16 Spread risk tool (SCR.5.67 to SCR.5.103) This tool allows the user to calculate the spread risk values, which are required as input in the I.Assets sheet in the main spreadsheet. Counterparty default risk tool (SCR.6.1 to SCR.6.58) This tool allows the user to calculate the counterparty default exposures values, which are required as input in the I.Assets sheet in the main spreadsheet. The Concentration risk tool (SCR to SCR 5.127) This tool allows the user to calculate the concentration amounts, which are required as input in the I.Assets sheet in the main spreadsheet. Adjustment for non proportional reinsurance tool (SCR.9.25 to SCR.9.28, Annex N) This tool allows the user to calculate an adjustment factor to be applied on the SCR for premium risk, for those lines of business that are affected by a non-proportional reinsurance, and input it in the SF.SCR sheet in the main spreadsheet. The Natural Catastrophes risk (SCR.9.62 to SCR.9.92) and the Man made cat risk (SCR.9.93 to SCR.9.166) tools These tools allow user to calculate the values required for the Cat Risk SCR for life and non-life business based on specific scenarios and parameters, and input them in the SF.SCR sheet in the main spreadsheet. Health Cat risk tool (SCR.8.95 to SCR.8.138) With this tool, the user can calculate the values required for the Cat Risk SCR for health SLT & Non-SLT business (accident & sickness classes) based on specific scenarios and parameters, and input them in the Health Cat Risk section of the SF.SCR sheet in the main spreadsheet.

17 17 Tool for extrapolation of the risk free rates This tool can be used for the extrapolation of the set of the risk free interest rates, which the user is going to use for the discounting of cash-flows (in combination with the Discounting tool mentioned above). A number of options for the illiquidity premium-loading are also available in this tool.

18 18 6. The QIS5 Questionnaires Qualitative questionnaire - solo Qualitative questionnaire - groups Qualitative questionnaire - internal models Qualitative questionnaire - Excel Very important tips: You must submit to us the latest version released by CEIOPS for each file. Thus it is imperative that you make use of every new version that is released during the process, and use the relevant transfer of data files to transfer your input in previous versions into the new ones. The main spreadsheet must be correctly and fully completed and submitted on time in order for ICCS to be able to take it in account for the National Report. Do not leave any parts from the input cells empty and do not enter any data in cells which are not designated for data entry. Where there are drop down menus you must select one of the options provided. Do not leave empty. Do not leave any of the spreadsheet s internal checks, on a False status. Make sure all internal checks are in True status. Delete any sheets you will not be using, e.g. sheets for insurance group undertakings and internal models information sheets.

19 19 Do not change the names of the spreadsheets-files, especially those that have links with others and/or use macros to transfer data between files. Give complete answers in the questionnaires. Write down all the information that will allow us to understand the methods and approaches you used and the problems you encountered. Also, if a certain approach and set of parameters is affecting your results dramatically and you think a different approach and/or set of parameters should be used, write this down, substantiate it, disclose the financial effects and give your suggestion. 7.?? QIS6?? It is possible. If there is going to be a QIS6 it will be targeted for specific issues, either current issues for which the QIS5 result may not give enough light or any new issues that may come up in the way, and for retesting specific parameters.

20 20 Appendix: SCR Tree SCR Adj BSCR Op Market Health Default Life Non-life Intang Interest rate SLT Health CAT Non-SLT Health Mortality Premium Reserve Equity Property Spread Mortality Longevity Disability Morbidity Premium Reserve Lapse Longevity Disability Morbidity Lapse Lapse CAT Currency Concentration Illiquidity Lapse Expenses Revision Expenses Revision CAT = included in the adjustment for the lossabsorbing capacity of technical provisions under the modular approach

CEIOPS-QIS5-06/10 6 September 2010

CEIOPS-QIS5-06/10 6 September 2010 CEIOPS-QIS5-06/10 6 September 2010 Manual for the completion of the QIS5 spreadsheet (for solo undertakings) Please note that this manual is not part of the formal QIS5 documentation as issued by the European

More information

QIS5 Workshops. Mark Burke, Graham Cherry, Dermot Marron

QIS5 Workshops. Mark Burke, Graham Cherry, Dermot Marron QIS5 Workshops Mark Burke, Graham Cherry, Dermot Marron 8 th 14 th September 2010 Agenda Overview Technical Provisions Assets and Other Liabilities SCR Own Funds Closing Remarks Discussion QIS5 Overview

More information

Solvency II for Beginners 16.05.2013

Solvency II for Beginners 16.05.2013 Solvency II for Beginners 16.05.2013 Agenda Why has Solvency II been created? Structure of Solvency II The Solvency II Balance Sheet Pillar II & III Aspects Where are we now? Solvency II & Actuaries Why

More information

Solvency II Pillar III Quantitative Reporting Templates (QRTs) Sinead Clarke, Eoin King 11 th December 2012

Solvency II Pillar III Quantitative Reporting Templates (QRTs) Sinead Clarke, Eoin King 11 th December 2012 Solvency II Pillar III Quantitative Reporting Templates (QRTs) Sinead Clarke, Eoin King 11 th December 2012 Agenda Introduction and Background Summary of QRTs Reporting Timelines and Next Steps Questions

More information

SA QIS3 Key changes and challenges The end is in sight

SA QIS3 Key changes and challenges The end is in sight SA QIS3 Key changes and challenges The end is in sight December 2013 Contents Introduction 1 Balance sheet 2 Assets and liabilities other than technical provisions 3 Technical provisions 4 Segmentation

More information

Solvency 2 Preparatory Phase. Comparison with LTGA specifications. June 2014

Solvency 2 Preparatory Phase. Comparison with LTGA specifications. June 2014 Solvency 2 Preparatory Phase Comparison with LTGA specifications June 2014 Summary This document presents: An analysis of the main changes between the Technical Specifications of the Long Term Guarantee

More information

SCOR inform - April 2012. Life (re)insurance under Solvency II

SCOR inform - April 2012. Life (re)insurance under Solvency II SCOR inform - April 2012 Life (re)insurance under Solvency II Life (re)insurance under Solvency II Author Thorsten Keil SCOR Global Life Cologne Editor Bérangère Mainguy Tel: +33 (0)1 58 44 70 00 Fax:

More information

Solvency II Standard Model for Health Insurance Business

Solvency II Standard Model for Health Insurance Business Solvency II Standard Model for Health Insurance Business Hanno Reich KPMG AG, Germany kpmg Agenda 1. Solvency II Project 2. Future regulatory framework (Solvency II) 3. Calculation of Solvency Capital

More information

An update on QIS5. Agenda 4/27/2010. Context, scope and timelines The draft Technical Specification Getting into gear Questions

An update on QIS5. Agenda 4/27/2010. Context, scope and timelines The draft Technical Specification Getting into gear Questions A Closer Look at Solvency II Eleanor Beamond-Pepler, FSA An update on QIS5 2010 The Actuarial Profession www.actuaries.org.uk Agenda Context, scope and timelines The draft Technical Specification Getting

More information

Fourth study of the Solvency II standard approach

Fourth study of the Solvency II standard approach Solvency Consulting Knowledge Series Your contacts Kathleen Ehrlich Tel.: +49 (89) 38 91-27 77 E-mail: kehrlich@munichre.com Dr. Rolf Stölting Tel.: +49 (89) 38 91-52 28 E-mail: rstoelting@munichre.com

More information

Solvency II Introduction to Pillar 3. Friday 20 th May 2016

Solvency II Introduction to Pillar 3. Friday 20 th May 2016 Solvency II Introduction to Pillar 3 Friday 20 th May 2016 Disclaimer The views expressed in this presentation are those of the presenter(s) and not necessarily of the Society of Actuaries in Ireland Introduction

More information

SOLVENCY II HEALTH INSURANCE

SOLVENCY II HEALTH INSURANCE 2016 Solvency II Health SOLVENCY II HEALTH INSURANCE 1 Overview 1.1 Background and scope The key objectives of Solvency II were to increase the level of harmonisation of solvency regulation across Europe,

More information

SOLVENCY II LIFE INSURANCE

SOLVENCY II LIFE INSURANCE 2016 Solvency II Life SOLVENCY II LIFE INSURANCE 1 Overview 1.1 Background and scope The key objectives of Solvency II were to increase the level of harmonisation of solvency regulation across Europe,

More information

CEIOPS-DOC-36/09. (former CP 42) October 2009

CEIOPS-DOC-36/09. (former CP 42) October 2009 CEIOPS-DOC-36/09 Final CEIOPS Advice for Level 2 Implementing Measures on Solvency II: Technical Provisions Article 86 (d) Calculation of the Risk Margin (former CP 42) October 2009 CEIOPS e.v. Westhafenplatz

More information

Consultation Paper on the Proposal for Guidelines on submission of information to national competent authorities

Consultation Paper on the Proposal for Guidelines on submission of information to national competent authorities EIOPA-CP-13/010 27 March 2013 Consultation Paper on the Proposal for Guidelines on submission of information to national competent authorities Page 1 of 268 Table of Contents Responding to this paper...

More information

SOLVENCY II HEALTH INSURANCE

SOLVENCY II HEALTH INSURANCE 2014 Solvency II Health SOLVENCY II HEALTH INSURANCE 1 Overview 1.1 Background and scope The current UK regulatory reporting regime is based on the EU Solvency I Directives. Although the latest of those

More information

SCHEDULE TO INSURANCE GROUP SUPERVISION AMENDMENT RULES 2015 SCHEDULE 3 (Paragraph 30) SCHEDULE OF FINANCIAL CONDITION REPORT OF INSURANCE GROUP [blank] name of Parent The schedule of Financial Condition

More information

FSA UK Country Report

FSA UK Country Report Financial Services Authority FSA UK Country Report The fifth Quantitative Impact Study (QIS5) for Solvency II March 2011 Contents 1 Introduction 3 2 Participation 6 3 Quality 8 4 Preparedness and resourcing

More information

SOLVENCY II LIFE INSURANCE

SOLVENCY II LIFE INSURANCE SOLVENCY II LIFE INSURANCE 1 Overview 1.1 Background and scope The current UK regulatory reporting regime is based on the EU Solvency I Directives. Although the latest of those Directives was implemented

More information

THE INSURANCE BUSINESS (SOLVENCY) RULES 2015

THE INSURANCE BUSINESS (SOLVENCY) RULES 2015 THE INSURANCE BUSINESS (SOLVENCY) RULES 2015 Table of Contents Part 1 Introduction... 2 Part 2 Capital Adequacy... 4 Part 3 MCR... 7 Part 4 PCR... 10 Part 5 - Internal Model... 23 Part 6 Valuation... 34

More information

1. INTRODUCTION AND PURPOSE

1. INTRODUCTION AND PURPOSE Solvency Assessment and Management: Pillar 1 - Sub Committee Capital Requirements Task Group Discussion Document 73 (v 2) Treatment of new business in SCR EXECUTIVE SUMMARY As for the Solvency II Framework

More information

Solvency Assessment and Management: Capital Requirements Discussion Document 58 (v 3) SCR Structure Credit and Counterparty Default Risk

Solvency Assessment and Management: Capital Requirements Discussion Document 58 (v 3) SCR Structure Credit and Counterparty Default Risk Solvency Assessment and Management: Capital Requirements Discussion Document 58 (v 3) SCR Structure Credit and Counterparty Default Risk EXECUTIVE SUMMARY Solvency II allows for credit and counterparty

More information

Solvency II. 2014 Standard Formula Exercise Guidance Notes. February 2014

Solvency II. 2014 Standard Formula Exercise Guidance Notes. February 2014 Solvency II 2014 Standard Formula Exercise Guidance Notes February 2014 Disclaimer No responsibility of liability is accepted by the Society of Lloyd s, the Council, or any Committee of Board constituted

More information

Report on the findings

Report on the findings Parallel Run on the Valuation of Long Term Insurance Business, Risk Based Capital Requirements for Insurers and Non-Life Outstanding Claims Reserves. Report on the findings TABLE OF CONTENTS EXECUTIVE

More information

Public Report. November 2007

Public Report. November 2007 CEIOPS-DOC-19/07 CEIOPS Report on its third Quantitative Impact Study (QIS3) for Solvency II Public Report November 2007 CEIOPS e.v. - Westhafenplatz 1 60327 Frankfurt am Main Germany Tel. + 49 69-951119-20

More information

02/06/2014. Solvency II update. Agenda. Recap: Solvency II three pillar approach. Nick Ford

02/06/2014. Solvency II update. Agenda. Recap: Solvency II three pillar approach. Nick Ford Solvency II update Nick Ford 02 June 2014 Agenda Intro and brief recap Pillar 1 Main issues Impacts on products Pillar 2 Main issues Internal Model Approval Pillar 3 Actuarial forms and concerns Timelines

More information

Solvency II: Hot topics for life insurers from the latest draft level 2 and level 3 measures. Jim Murphy Andrew Kay

Solvency II: Hot topics for life insurers from the latest draft level 2 and level 3 measures. Jim Murphy Andrew Kay Solvency II: Hot topics for life insurers from the latest draft level 2 and level 3 measures Jim Murphy Andrew Kay Solvency II Framework slide 2 Pillar 1 Solvency II Framework Pillar 2 Pillar 3 Measurement

More information

Guidelines on ring-fenced funds

Guidelines on ring-fenced funds EIOPA-BoS-14/169 EN Guidelines on ring-fenced funds EIOPA Westhafen Tower, Westhafenplatz 1-60327 Frankfurt Germany - Tel. + 49 69-951119-20; Fax. + 49 69-951119-19; email: info@eiopa.europa.eu site: https://eiopa.europa.eu/

More information

KPMG Business DialogueS

KPMG Business DialogueS KPMG Business DialogueS KPMG Luxembourg May 30, 2012 Solvency II, Pillar 3 Chrystelle Veeckmans, Director, Audit services Geoffroy Gailly, Director, Management Consulting Pascal Föhr, Senior Manager, Audit

More information

Questions & Answers as of 6 Feb 2013 06 February 2013

Questions & Answers as of 6 Feb 2013 06 February 2013 LongTerm Guarantees Assessment Questions & s as of 6 Feb 2013 EIOPA/13/067 06 February 2013 ID Document Topic No. Question TS part I TP! Segmentation 1005a TS part I TP Segmentation TP 1.14 In relation

More information

International Financial Reporting for Insurers: IFRS and U.S. GAAP September 2009 Session 25: Solvency II vs. IFRS

International Financial Reporting for Insurers: IFRS and U.S. GAAP September 2009 Session 25: Solvency II vs. IFRS International Financial Reporting for Insurers: IFRS and U.S. GAAP September 2009 Session 25: Solvency II vs. IFRS Simon Walpole Solvency II Simon Walpole Solvency II Agenda Introduction to Solvency II

More information

Insurance Groups under Solvency II

Insurance Groups under Solvency II Insurance Groups under Solvency II November 2013 Table of Contents 1. Introduction... 2 2. Defining an insurance group... 2 3. Cases of application of group supervision... 6 4. The scope of group supervision...

More information

CEIOPS-DOC-45/09. (former CP 53) October 2009

CEIOPS-DOC-45/09. (former CP 53) October 2009 CEIOPS-DOC-45/09 CEIOPS Advice for Level 2 Implementing Measures on Solvency II: SCR standard formula - Article 111 (f) Operational Risk (former CP 53) October 2009 CEIOPS e.v. Westhafenplatz 1-60327 Frankfurt

More information

Solvency II in practice. Speaker: Tim O Hanrahan Deputy Head, Insurance, Central Bank of Ireland 16 March 2016

Solvency II in practice. Speaker: Tim O Hanrahan Deputy Head, Insurance, Central Bank of Ireland 16 March 2016 1 Solvency II in practice Speaker: Tim O Hanrahan Deputy Head, Insurance, Central Bank of Ireland 16 March 2016 1 Recap on Solvency II Regulatory Framework under Solvency II Pillar I - Capital Pillar II

More information

The standard formula requires further adjustments

The standard formula requires further adjustments EIOPA publishes the results of the fifth quantitative impact study (QIS5) The standard formula requires further adjustments Authors Martin Brosemer Dr. Kathleen Ehrlich Dr. Norbert Kuschel Lars Moormann

More information

Quantitative Impact Study 1 (QIS1) Summary Report for Belgium. 21 March 2006

Quantitative Impact Study 1 (QIS1) Summary Report for Belgium. 21 March 2006 Quantitative Impact Study 1 (QIS1) Summary Report for Belgium 21 March 2006 1 Quantitative Impact Study 1 (QIS1) Summary Report for Belgium INTRODUCTORY REMARKS...4 1. GENERAL OBSERVATIONS...4 1.1. Market

More information

Solvency II overview

Solvency II overview David Payne, FIA Casualty Loss Reserve Seminar 15 September 2011 INTNL-2: Solvency II Update Antitrust Notice The Casualty Actuarial Society is committed to adhering strictly to the letter and spirit of

More information

CEIOPS Preparatory Field Study for Life Insurance Firms. Summary Report

CEIOPS Preparatory Field Study for Life Insurance Firms. Summary Report CEIOPS-FS-08/05 S CEIOPS Preparatory Field Study for Life Insurance Firms Summary Report 1 GENERAL OBSERVATIONS AND CONCLUSIONS 1.1 Introduction CEIOPS has been asked to prepare advice for the European

More information

OECD INSURANCE STATISTICS

OECD INSURANCE STATISTICS ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT ORGANISATION DE COOPÉRATION ET DE DÉVELOPPEMENT ÉCONOMIQUES DIRECTION DES AFFAIRES FINANCIÈRES ET DES ENTREPRISES DIRECTORATE FOR FINANCIAL AND ENTERPRISE

More information

What alternative investments are of interest to life companies?

What alternative investments are of interest to life companies? Life Conference 2011 Scott Robertson and Niall Clifford, KPMG LLP What alternative investments are of interest to life companies? 21 November 2011 Contents 1. What alternative assets have low correlation

More information

LIFE INSURANCE RATING METHODOLOGY CREDIT RATING AGENCY OF

LIFE INSURANCE RATING METHODOLOGY CREDIT RATING AGENCY OF LIFE INSURANCE RATING METHODOLOGY CREDIT RATING AGENCY OF BANGLADESH LIMITED 1 CRAB S RATING PROCESS An independent and professional approach of the CRAB is designed to ensure reliable, consistent and

More information

Capital requirements for health insurance under Solvency II

Capital requirements for health insurance under Solvency II Capital requirements for health insurance under Solvency II Medical Expense Insurance: Actuarial Aspects and Solvency Afternoon Seminar at the AG Insurance Chair in Health Insurance, KU Leuven 25 April

More information

Solvency II Conference. 29 November 2011

Solvency II Conference. 29 November 2011 Solvency II Conference 29 November 2011 Agenda Topic Opening Remarks Update on Solvency II Programme European Context and Local Perspective Overview of Pillar 1 Coffee Break Move to Breakout Rooms Breakout

More information

CEIOPS-DOC-43/09. (former CP 50) October 2009

CEIOPS-DOC-43/09. (former CP 50) October 2009 CEIOPS-DOC-43/09 CEIOPS Advice for Level 2 Implementing Measures on Solvency II: SCR standard formula - underwriting risk module (former CP 50) October 2009 CEIOPS e.v. Westhafenplatz 1-60327 Frankfurt

More information

Actuarial Risk Management

Actuarial Risk Management ARA syllabus Actuarial Risk Management Aim: To provide the technical skills to apply the principles and methodologies studied under actuarial technical subjects for the identification, quantification and

More information

Treatment of technical provisions under Solvency II

Treatment of technical provisions under Solvency II Treatment of technical provisions under Solvency II Quantitative methods, qualitative requirements and disclosure obligations Authors Martin Brosemer Dr. Susanne Lepschi Dr. Katja Lord Contact solvency-solutions@munichre.com

More information

Important note: This document is a working document of the Commission services for discussion. It does not purport to represent or pre-judge the

Important note: This document is a working document of the Commission services for discussion. It does not purport to represent or pre-judge the DRAFT Technical specifications for QIS 5 Important note: This document is a working document of the Commission services for discussion. It does not purport to represent or pre-judge the formal proposals

More information

CEIOPS-DOC-33/09. (former CP 39) October 2009

CEIOPS-DOC-33/09. (former CP 39) October 2009 CEIOPS-DOC-33/09 CEIOPS Advice for Level 2 Implementing Measures on Solvency II: Technical provisions Article 86 a Actuarial and statistical methodologies to calculate the best estimate (former CP 39)

More information

PART H GUIDANCE ON COMPLETION OF THE BUSINESS OF INSURANCE STATEMENTS

PART H GUIDANCE ON COMPLETION OF THE BUSINESS OF INSURANCE STATEMENTS S C H E D U L E (Articles 4 to 6) PART H GUIDANCE ON COMPLETION OF THE BUSINESS OF INSURANCE STATEMENTS Introduction 1. Authorised companies should begin by compiling the worksheet named Cover Sheet, by

More information

Solvency II Technical Provisions valuation as at 31st december 2010. submission template instructions

Solvency II Technical Provisions valuation as at 31st december 2010. submission template instructions Solvency II Technical Provisions valuation as at 31st december 2010 submission template instructions Introduction As set out in the Guidance Notes for the 2011 Dry Run Review Process, calculation of Technical

More information

SOLVENCY II GENERAL INSURANCE

SOLVENCY II GENERAL INSURANCE SOLVENCY II GENERAL INSURANCE 1 Solvency II 1.1 Background to development of Solvency II During the development of Solvency II key objectives were maintained: to increase the level of harmonisation of

More information

Feedback on the 2012 thematic review of technical provisions

Feedback on the 2012 thematic review of technical provisions Feedback on the 2012 thematic review of technical provisions Introduction Background In late 2012 the FSA published a question bank 1 on Solvency II (SII) technical provisions for completion by general

More information

Guidelines on the valuation of technical provisions

Guidelines on the valuation of technical provisions EIOPA-BoS-14/166 EN Guidelines on the valuation of technical provisions EIOPA Westhafen Tower, Westhafenplatz 1-60327 Frankfurt Germany - Tel. + 49 69-951119-20; Fax. + 49 69-951119-19; email: info@eiopa.europa.eu

More information

CEIOPS-DOC-22/09. (former CP27) October 2009. CEIOPS e.v. Westhafenplatz 1-60327 Frankfurt Germany Tel. + 49 69-951119-20

CEIOPS-DOC-22/09. (former CP27) October 2009. CEIOPS e.v. Westhafenplatz 1-60327 Frankfurt Germany Tel. + 49 69-951119-20 CEIOPS-DOC-22/09 CEIOPS Advice for Level 2 Implementing Measures on Solvency II: Technical Provisions - Lines of business on the basis of which (re)insurance obligations are to be segmented (former CP27)

More information

Solvency II: Implications for Loss Reserving

Solvency II: Implications for Loss Reserving Solvency II: Implications for Loss Reserving John Charles Doug Collins CLRS: 12 September 2006 Agenda Solvency II Introduction Pre-emptive adopters Solvency II concepts Quantitative Impact Studies Internal

More information

CEIOPS-DOC-47/09. (former CP 55) October 2009

CEIOPS-DOC-47/09. (former CP 55) October 2009 CEIOPS-DOC-47/09 Final CEIOPS Advice for Level 2 Implementing Measures on Solvency II: Article 130 Calculation of the MCR (former CP 55) October 2009 CEIOPS e.v. Westhafenplatz 1-60327 Frankfurt Germany

More information

2014 Head office: Ballam Road, Lytham St.Annes, FY8 4JZ Annual PRA Insurance Returns for the year ended 31 December 2014 IPRU(INS) Appendices 9.1, 9.2, 9.3, 9.4, 9.4A, 9.5, 9.6 Balance Sheet and Profit

More information

Friends Life Limited

Friends Life Limited Annual PRA Insurance Returns for the year ended 31 December 2014 IPRU(INS) Appendices 9.1, 9.3, 9.4, 9.4A, 9.6 Balance Sheet and Profit and Loss Account Contents Form 2 Statement of solvency - long-term

More information

Revised Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I)

Revised Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I) EIOPA-DOC-12/467 21 December 2012 Revised Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I) This technical specification is a working document

More information

The Prudential Assurance Company Limited

The Prudential Assurance Company Limited The Prudential Assurance Company Limited Annual PRA Insurance Returns for the year ended 31 December 2015 IPRU(INS) Appendices 9.1, 9.2, 9.3, 9.4, 9.4A, 9.5, 9.6 Balance Sheet and Profit and Loss Account

More information

INVESTMENT FUNDS: Funds investments. KPMG Business DialogueS November 4 th 2011

INVESTMENT FUNDS: Funds investments. KPMG Business DialogueS November 4 th 2011 INVESTMENT FUNDS: Impact of Solvency II Directive on Funds investments KPMG Business DialogueS November 4 th 2011 Map of the presentation Introduction The first consequences for asset managers and investors

More information

GLOSSARY. A contract that provides for periodic payments to an annuitant for a specified period of time, often until the annuitant s death.

GLOSSARY. A contract that provides for periodic payments to an annuitant for a specified period of time, often until the annuitant s death. The glossary contains explanations of certain terms and definitions used in this prospectus in connection with us and our business. The terms and their meanings may not correspond to standard industry

More information

THE EQUITABLE LIFE ASSURANCE SOCIETY

THE EQUITABLE LIFE ASSURANCE SOCIETY THE EQUITABLE LIFE ASSURANCE SOCIETY Annual PRA Insurance Returns for the year ended 31 December 2013 Appendices 9.1, 9.3, 9.4, 9.4A & 9.6 from the Interim Prudential Sourcebook for Insurers Registered

More information

Fifth Quantitative Impact Study of Solvency II (QIS5)

Fifth Quantitative Impact Study of Solvency II (QIS5) Fifth Quantitative Impact Study of Solvency II (QIS5) Guidance on the treatment of German accident insurance with guaranteed premium repayment in the solvency balance sheet of QIS5 Introduction The UBR

More information

Towards the strengthening and moderinsation of insurance and surety regulation

Towards the strengthening and moderinsation of insurance and surety regulation Non-Life Insurance Technical Provisions i Towards the strengthening and moderinsation of insurance and surety regulation XXI International Seminar on Insurance and Surety, November 2010, Mexico City Olaf

More information

Insurance Roadshow London, October 2008. Solvency 2 Update

Insurance Roadshow London, October 2008. Solvency 2 Update Insurance Roadshow London, October 2008 Solvency 2 Update Agenda Progress to date Overview of key component of Solvency 2 Further issues for discussion Impact on ratings Solvency 2 - What s new? Progress

More information

Embedded Value Report

Embedded Value Report Embedded Value Report 2012 ACHMEA EMBEDDED VALUE REPORT 2012 Contents Management summary 3 Introduction 4 Embedded Value Results 5 Value Added by New Business 6 Analysis of Change 7 Sensitivities 9 Impact

More information

Life Insurance Corporation (Singapore)Pte Ltd UEN 201210695E MANAGEMENT REPORT 31/12/2014

Life Insurance Corporation (Singapore)Pte Ltd UEN 201210695E MANAGEMENT REPORT 31/12/2014 Life Insurance Corporation (Singapore)Pte Ltd UEN 201210695E MANAGEMENT REPORT 31/12/2014 LIFE INSURANCE CORPORATION (SINGAPORE) PTE. LTD. For the financial year from 1 January 2014 to 31 December 2014

More information

Revised Annexes to the Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I)

Revised Annexes to the Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I) EIOPA-DOC-12/467 21 December 2012 Revised Annexes to the Technical Specifications for the Solvency II valuation and Solvency Capital Requirements calculations (Part I) 1 TABLE OF CONTENT ANNEX A - DEFINITION

More information

SAS AND CRYSTAL SYSTEM EMPOWERING SOLVENCY II FIAR - THE INTERNATIONAL INSURANCE-REINSURANCE FORUM 2014, BRASOV

SAS AND CRYSTAL SYSTEM EMPOWERING SOLVENCY II FIAR - THE INTERNATIONAL INSURANCE-REINSURANCE FORUM 2014, BRASOV SAS AND CRYSTAL SYSTEM EMPOWERING SOLVENCY II FIAR - THE INTERNATIONAL INSURANCE-REINSURANCE FORUM 2014, BRASOV HIGH PERFORMANCE ANALYTICS CRYSTAL SYSTEM 2001 Crystal System Bucharest Near-Shore factory

More information

GUIDANCE NOTE 253 - DETERMINATION OF LIFE INSURANCE POLICY LIABILITIES

GUIDANCE NOTE 253 - DETERMINATION OF LIFE INSURANCE POLICY LIABILITIES THE INSTITUTE OF ACTUARIES OF AUSTRALIA A.C.N. 000 423 656 GUIDANCE NOTE 253 - DETERMINATION OF LIFE INSURANCE POLICY LIABILITIES APPLICATION Appointed Actuaries of Life Insurance Companies. LEGISLATION

More information

Solvency II and catastrophe

Solvency II and catastrophe Solvency II and catastrophe risks: Measurement approaches for propertycasualty insurers Country-specific requirements or standard formula? Authors: Dr. Kathleen Ehrlich Dr. Norbert Kuschel Contact solvency-solutions@munichre.com

More information

Aviva Insurance UK Limited

Aviva Insurance UK Limited Annual FSA Insurance Returns for the ended st December (Appendices 9.1, 9.2, 9.5, 9.6) Produced using BestESP Services - UK AVIVA INSURANCE UK LIMITED Year ended st December Contents The companies included

More information

EIOPA technical specifications for Long-Term Guarantee Assessment. January 2013. Milliman Solvency II Update

EIOPA technical specifications for Long-Term Guarantee Assessment. January 2013. Milliman Solvency II Update EIOPA technical specifications for Long-Term Guarantee Assessment January 2013 The Long-Term Guarantee Assessment requires participating firms to test the application of the proposed package of measures

More information

Best Estimate of the Technical Provisions

Best Estimate of the Technical Provisions Best Estimate of the Technical Provisions FSI Regional Seminar for Supervisors in Africa on Risk Based Supervision Mombasa, Kenya, 14-17 September 2010 Leigh McMahon BA FIAA GAICD Senior Manager, Diversified

More information

INSPRU overview. Paul Edmondson T: +44 20 7367 2877 E: paul.edmondson@cms-cmck.com. November 2013

INSPRU overview. Paul Edmondson T: +44 20 7367 2877 E: paul.edmondson@cms-cmck.com. November 2013 INSPRU overview Paul Edmondson T: +44 20 7367 2877 E: paul.edmondson@cms-cmck.com November 2013 Three rules Insurers must maintain assets to meet liabilities maintain capital only carry on insurance business

More information

1. This Prudential Standard is made under paragraph 230A(1)(a) of the Life Insurance Act 1995 (the Act).

1. This Prudential Standard is made under paragraph 230A(1)(a) of the Life Insurance Act 1995 (the Act). Prudential Standard LPS 110 Capital Adequacy Objective and key requirements of this Prudential Standard This Prudential Standard requires a life company to maintain adequate capital against the risks associated

More information

SOLVENCY II Level 2 Implementing Measures

SOLVENCY II Level 2 Implementing Measures SOLVENCY II Level 2 Implementing Measures Executive Summary Position After the Three Waves of Consultation Papers and the Quantitative Impact Study 5 Technical Specifications August 2010 The data and information

More information

Hot Topic. Reporting requirements under Solvency II move forward

Hot Topic. Reporting requirements under Solvency II move forward Reporting requirements under Solvency II move forward FS Regulatory Centre of Excellence 9 vember 2011 Summary Latest proposals from EIOPA provide insurers with a largely stabilised package of quantitative

More information

Solvency Management in Life Insurance The company s perspective

Solvency Management in Life Insurance The company s perspective Group Risk IAA Seminar 19 April 2007, Mexico City Uncertainty Exposure Solvency Management in Life Insurance The company s perspective Agenda 1. Key elements of Allianz Risk Management framework 2. Drawbacks

More information

Aviva Insurance Limited

Aviva Insurance Limited Annual FSA Insurance Returns for the ended st December (Appendices 9.1, 9.2, 9.5, 9.6) Produced using BestESP Services - UK Year ended st December Contents Page Appendix 9.1 Form 1 Statement of solvency

More information

INTERNATIONAL ASSOCIATION OF INSURANCE SUPERVISORS

INTERNATIONAL ASSOCIATION OF INSURANCE SUPERVISORS Standard No. 13 INTERNATIONAL ASSOCIATION OF INSURANCE SUPERVISORS STANDARD ON ASSET-LIABILITY MANAGEMENT OCTOBER 2006 This document was prepared by the Solvency and Actuarial Issues Subcommittee in consultation

More information

Evaluatie QIS5 16 december 2010. Out of the box actuaries and risk professionals

Evaluatie QIS5 16 december 2010. Out of the box actuaries and risk professionals Evaluatie 16 december 2010 Out of the box actuaries and risk professionals Agenda Introduction results Demo: manage process using E2S Appendix 1: detailed results non-life 2 Introduction Planning and participation

More information

NST.06 - Non-life Insurance Claims Information - Detailed split by Distribution Channel and Claims Type.

NST.06 - Non-life Insurance Claims Information - Detailed split by Distribution Channel and Claims Type. NST.06 - Non-life Insurance Claims Information - Detailed split by Distribution Channel and Claims Type. The first column of the next table identifies the items to be reported by identifying the columns

More information

EIOPACP 13/011. Guidelines on PreApplication of Internal Models

EIOPACP 13/011. Guidelines on PreApplication of Internal Models EIOPACP 13/011 Guidelines on PreApplication of Internal Models EIOPA Westhafen Tower, Westhafenplatz 1 60327 Frankfurt Germany Tel. + 49 6995111920; Fax. + 49 6995111919; site: www.eiopa.europa.eu Guidelines

More information

PART A AUTHORISATION FOR CARRYING ON BUSINESS OF INSURANCE

PART A AUTHORISATION FOR CARRYING ON BUSINESS OF INSURANCE PART A AUTHORISATION FOR CARRYING ON BUSINESS OF INSURANCE Chapter 1: The Application Process 1.1 Introduction 1.1.1 The application for authorisation to carry on business of insurance shall be considered

More information

Solvency II. Balance sheet submission. Instructions February 2012

Solvency II. Balance sheet submission. Instructions February 2012 Solvency II Balance sheet submission Instructions February 2012 Contents Introduction Purpose & Scope 3 Balance Sheet as at 31 December 2011 3 Balance Sheet as at 30 June 2012 3 Next steps 4 Instructions

More information

FINANCIAL REVIEW. 18 Selected Financial Data 20 Management s Discussion and Analysis of Financial Condition and Results of Operations

FINANCIAL REVIEW. 18 Selected Financial Data 20 Management s Discussion and Analysis of Financial Condition and Results of Operations 2012 FINANCIAL REVIEW 18 Selected Financial Data 20 Management s Discussion and Analysis of Financial Condition and Results of Operations 82 Quantitative and Qualitative Disclosures About Market Risk 88

More information

Legal & General Insurance Limited

Legal & General Insurance Limited Annual PRA Insurance Returns for the ended 31 December 2014 IPRU(INS) Appendices 9.1, 9.2, 9.5, 9.6 Balance Sheet and Profit and Loss Account Contents Form 1 Statement of solvency - general insurance

More information

Hot Topic FS Regulatory Centre of Excellence, 2 December 2013. Hot Topic. Solvency II requirements published

Hot Topic FS Regulatory Centre of Excellence, 2 December 2013. Hot Topic. Solvency II requirements published Hot Topic Hot Topic Solvency II requirements published The publication of the Omnibus II text provides much needed clarity to the market on some key topics FS Regulatory Centre of Excellence 2 December

More information

Solvency II: An update on implementation

Solvency II: An update on implementation Solvency II: An update on implementation Introduction Solvency II will apply from 1 January 2016. Firms have made significant progress towards compliance with the new regime. The PRA will publish a consultation

More information

METHODOLOGY OF THE RISK ASSESSMENT FRAMEWORK (BION) FOR INSURANCE AND REINSURANCE UNDERTAKINGS

METHODOLOGY OF THE RISK ASSESSMENT FRAMEWORK (BION) FOR INSURANCE AND REINSURANCE UNDERTAKINGS METHODOLOGY OF THE RISK ASSESSMENT FRAMEWORK (BION) FOR INSURANCE AND REINSURANCE UNDERTAKINGS Warsaw, 2014 TABLE OF CONTENTS 1. THE CONCEPT OF THE RISK ASSESSMENT FRAMEWORK (BION) FOR INSURANCE AND REINSURANCE

More information

EIOPA-CP-11/008 7 November 2011. Consultation Paper On the Proposal for Guidelines on Own Risk and Solvency Assessment

EIOPA-CP-11/008 7 November 2011. Consultation Paper On the Proposal for Guidelines on Own Risk and Solvency Assessment EIOPA-CP-11/008 7 November 2011 Consultation Paper On the Proposal for Guidelines on Own Risk and Solvency Assessment EIOPA Westhafen Tower, Westhafenplatz 1-60327 Frankfurt Germany - Tel. + 49 69-951119-20;

More information

Impacts of the Solvency II Standard Formula on health insurance business in Germany

Impacts of the Solvency II Standard Formula on health insurance business in Germany Impacts of the Solvency II Standard Formula on health insurance business in Germany Sascha Raithel Association of German private healthcare insurers Agenda 1. Private health insurance business in Germany

More information

Capital Management in a Solvency II World & the Role of Reinsurance

Capital Management in a Solvency II World & the Role of Reinsurance Capital Management in a Solvency II World & the Role of Reinsurance Paolo de Martin CEO SCOR Global Life IAA Colloquium Oslo June 2015 Overview Why I Focus today on Capital Management? Reminder key objectives

More information

GN8: Additional Guidance on valuation of long-term insurance business

GN8: Additional Guidance on valuation of long-term insurance business GN8: Additional Guidance on valuation of long-term insurance business Classification Practice Standard MEMBERS ARE REMINDED THAT THEY MUST ALWAYS COMPLY WITH THE PROFESSIONAL CONDUCT STANDARDS (PCS) AND

More information

Introduction. Coverage. Principle 1: Embedded Value (EV) is a measure of the consolidated value of shareholders interests in the covered business.

Introduction. Coverage. Principle 1: Embedded Value (EV) is a measure of the consolidated value of shareholders interests in the covered business. Introduction Principle 1: Embedded Value (EV) is a measure of the consolidated value of shareholders interests in the covered business. G1.1 The EV Methodology ( EVM ) described here is applied to the

More information

Enterprise Risk Management in a Highly Uncertain World. A Presentation to the Government-University- Industry Research Roundtable June 20, 2012

Enterprise Risk Management in a Highly Uncertain World. A Presentation to the Government-University- Industry Research Roundtable June 20, 2012 Enterprise Risk Management in a Highly Uncertain World A Presentation to the Government-University- Industry Research Roundtable June 20, 2012 CRO Council Introduction Mission The North American CRO Council

More information

Financial Review. 16 Selected Financial Data 18 Management s Discussion and Analysis of Financial Condition and Results of Operations

Financial Review. 16 Selected Financial Data 18 Management s Discussion and Analysis of Financial Condition and Results of Operations 2011 Financial Review 16 Selected Financial Data 18 Management s Discussion and Analysis of Financial Condition and Results of Operations 82 Quantitative and Qualitative Disclosures About Market Risk 90

More information

Partnership Life Assurance Company Limited

Partnership Life Assurance Company Limited Partnership Life Assurance Company Limited Annual PRA Insurance Returns for the year ended 31 December 2013 IPRU(INS) Appendices 9.1, 9.3, 9.4, 9.6 Contents Balance Sheet and Profit and Loss Account Form

More information